Title Evaluation of Quality-of-Life (QOL) Assessment in Patients with Advanced Solid Malignancies as Screening Tool- Pilot Study on Implications on Eligibility and Adverse Events
Principal Investigator Grace Dy, MD
Study Number 192811
Summary This is a quality-of-life questionnaire study. Patients on a Phase I trial will take this survey at 4 separate times throughout their treatment.
- Must be consented to a Phase I therapeutic study.
- Must sign consent.
- Must be over 18.
- Must have advanced solid malignancies.